Published in Biochim Biophys Acta on January 22, 2016
A gene complex controlling segmentation in Drosophila. Nature (1978) 23.75
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature (2007) 21.53
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell (2004) 8.06
Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med (2012) 5.49
Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science (1996) 5.13
The Hox genes and their roles in oncogenesis. Nat Rev Cancer (2010) 3.97
Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature (2000) 3.78
Hox cofactors in vertebrate development. Dev Biol (2006) 3.58
Mutation of HOXA13 in hand-foot-genital syndrome. Nat Genet (1997) 3.40
A conserved retinoic acid response element required for early expression of the homeobox gene Hoxb-1. Nature (1994) 2.76
A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen. Clin Cancer Res (2006) 2.27
The cell-cycle regulator geminin inhibits Hox function through direct and polycomb-mediated interactions. Nature (2004) 2.19
A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer. Clin Cancer Res (2008) 2.16
HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. J Clin Invest (1998) 2.14
Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer Res (2011) 2.12
The homeodomain protein HOXB13 regulates the cellular response to androgens. Mol Cell (2009) 2.07
Endocrine regulation of HOX genes. Endocr Rev (2006) 2.04
Homozygous HOXA1 mutations disrupt human brainstem, inner ear, cardiovascular and cognitive development. Nat Genet (2005) 1.98
Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab (2002) 1.85
Limb malformations and the human HOX genes. Am J Med Genet (2002) 1.83
PBX and MEIS as non-DNA-binding partners in trimeric complexes with HOX proteins. Mol Cell Biol (1999) 1.66
Targeting long non-coding RNAs in cancers: progress and prospects. Int J Biochem Cell Biol (2013) 1.64
Identification of a retinoic acid responsive enhancer 3' of the murine homeobox gene Hox-1.6. Mech Dev (1992) 1.57
HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance. Cancer Discov (2015) 1.54
Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance. Int J Mol Sci (2012) 1.44
Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndrome. Am J Hum Genet (2000) 1.36
A HOXA13 allele with a missense mutation in the homeobox and a dinucleotide deletion in the promoter underlies Guttmacher syndrome. Hum Mutat (2002) 1.31
Genomic structure of HOXD13 gene: a nine polyalanine duplication causes synpolydactyly in two unrelated families. Hum Mol Genet (1996) 1.27
HOX genes and their role in the development of human cancers. J Mol Med (Berl) (2014) 1.26
Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab (2003) 1.26
The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer. Clin Cancer Res (2007) 1.26
The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway. Proc Natl Acad Sci U S A (2011) 1.24
The zebrafish hoxDb cluster has been reduced to a single microRNA. Nat Genet (2006) 1.23
Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker. J Natl Cancer Inst (2013) 1.19
Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer. Cancer Res (2014) 1.19
HOXA10 regulates p53 expression and matrigel invasion in human breast cancer cells. Cancer Biol Ther (2004) 1.18
The clinical spectrum of homozygous HOXA1 mutations. Am J Med Genet A (2008) 1.16
Identification of a retinoic acid response element upstream of the murine Hox-4.2 gene. Mol Cell Biol (1993) 1.13
Association of a HOXB13 variant with breast cancer. N Engl J Med (2012) 1.09
HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to retinoic acid-induced apoptosis and growth inhibition. Cancer Res (2007) 1.06
HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by suppressing ERα and inducing IL-6 expression. Cancer Res (2013) 1.05
Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment. Eur J Cancer (2013) 1.04
Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice. Sci Transl Med (2014) 1.03
LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer. Oncogene (2015) 1.03
A HOXA10 estrogen response element (ERE) is differentially regulated by 17 beta-estradiol and diethylstilbestrol (DES). J Mol Biol (2004) 1.02
A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family. Am J Hum Genet (2008) 1.01
Amegakaryocytic thrombocytopenia and radio-ulnar synostosis are associated with HOXA11 mutation. Nat Genet (2000) 1.00
HOXC10 is overexpressed in breast cancer and transcriptionally regulated by estrogen via involvement of histone methylases MLL3 and MLL4. J Mol Endocrinol (2012) 1.00
Interaction of developmental transcription factor HOXC11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer [corrected]. Cancer Res (2010) 1.00
A HOX gene mutation in a family with isolated congenital vertical talus and Charcot-Marie-Tooth disease. Am J Hum Genet (2004) 0.99
Direct regulation of HOXA10 by 1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells. Mol Endocrinol (2005) 0.99
A retinoic acid-triggered cascade of HOXB1 gene activation. Proc Natl Acad Sci U S A (1995) 0.98
HOXA11 silencing and endogenous HOXA11 antisense ribonucleic acid in the uterine endometrium. J Clin Endocrinol Metab (2002) 0.98
HOXB1 founder mutation in humans recapitulates the phenotype of Hoxb1-/- mice. Am J Hum Genet (2012) 0.96
BC-819, a plasmid comprising the H19 gene regulatory sequences and diphtheria toxin A, for the potential targeted therapy of cancers. Curr Opin Mol Ther (2010) 0.95
Retinoic acid receptors: from molecular mechanisms to cancer therapy. Mol Aspects Med (2014) 0.95
Loss-of-function mutations in HOXC13 cause pure hair and nail ectodermal dysplasia. Am J Hum Genet (2012) 0.94
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer. Sci Transl Med (2014) 0.94
ACK1 tyrosine kinase interacts with histone demethylase KDM3A to regulate the mammary tumor oncogene HOXA1. J Biol Chem (2014) 0.93
Role of Hox genes in stem cell differentiation. World J Stem Cells (2015) 0.91
Targeting HOX transcription factors in prostate cancer. BMC Urol (2014) 0.89
Evidence for two distinct retinoic acid response pathways for HOXB1 gene regulation. Proc Natl Acad Sci U S A (1995) 0.89
Deterministic HOX patterning in human pluripotent stem cell-derived neuroectoderm. Stem Cell Reports (2015) 0.89
Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer. Cancer Epidemiol (2013) 0.88
Mutation analysis of the HOX paralogous 4-13 genes in children with acute lymphoid malignancies: identification of a novel germline mutation of HOXD4 leading to a partial loss-of-function. Hum Mutat (2005) 0.85
Effects of aromatase inhibitors on human osteoblast and osteoblast-like cells: a possible androgenic bone protective effects induced by exemestane. Bone (2006) 0.83
Homeobox A7 stimulates breast cancer cell proliferation by up-regulating estrogen receptor-alpha. Biochem Biophys Res Commun (2013) 0.83
HOXA10 expression is repressed by progesterone in the myometrium: differential tissue-specific regulation of HOX gene expression in the reproductive tract. J Clin Endocrinol Metab (2001) 0.83
Autosomal dominant preaxial deficiency, postaxial polydactyly, and hypospadias. Am J Med Genet (1993) 0.82
Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4. BMC Cancer (2015) 0.81
Homeotic Complex (Hox) gene regulation and homeosis in the mesoderm of the Drosophila melanogaster embryo: the roles of signal transduction and cell autonomous regulation. Mech Dev (2001) 0.81
HOX gene methylation status analysis in patients with hereditary breast cancer. J Hum Genet (2012) 0.79
Tissue selective estrogen complexes (TSECs) differentially modulate markers of proliferation and differentiation in endometrial cells. Reprod Sci (2012) 0.79
Hox transcription factors: modulators of cell-cell and cell-extracellular matrix adhesion. Biomed Res Int (2014) 0.78
HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy. Oncotarget (2015) 0.76